<DOC>
	<DOCNO>NCT00563979</DOCNO>
	<brief_summary>The primary objective EMPOLS increase macular pigment density ( MPD ) contrast sensitivity ( CS ) six month supplementation oral non-compound ester Lutein 10 mg daily , contain VitaluxPlus® .</brief_summary>
	<brief_title>Enhancement Macular Pigment Density Oral Lutein Supplementation</brief_title>
	<detailed_description>The primary objective EMPOLS increase macular pigment density ( MPD ) contrast sensitivity ( CS ) six month supplementation oral non-compound ester Lutein 10 mg daily , contain VitaluxPlus® . Primary variable significant change 10 % increase compare baseline MPD . The measurement carry mean modify confocal scan laser ophthalmoscope ( HRA ) record autofluorescence image 488 nm 514 nm 6 . MPD determine MPD map within 0.5 degree around center fovea . All MPD measurement photograph perform Bern Photographic Reading Center ( BPRC ) . Complete examination study patient comprise test standardize visual acuity ( ETDRS-VA ) , visual contrast sensitivity ( CS ) , biomicroscopy , fundus photography , blood sample . Participating patient also fill food frequency questionnaire ( FFQ-Bern ) allow correction additional lutein intake regular diet . Moreover possible confound factor e.g . sunlight exposure smoke habit assess . Secondary objective EMPOLS effect oral non-compound ester lutein supplementation CS ETDRS-VA one year . The variable significant change ETDRS-VA loss gain 7 letter ETDRS chart , change CS : loss gain least four letter Pelli-Robson CS Chart . Additionally , serum carotenoid level lutein determine high performance liquid chromatography ( HPLC ) visit 1 .</detailed_description>
	<criteria>age relate maculopathy exudative age relate degeneration</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>age relate macular degeneration</keyword>
	<keyword>supplementation</keyword>
	<keyword>macular pigment</keyword>
</DOC>